Nishadil
Nishadil Ads Nishadil Astrology Nishadil Developers Nishadil Domains Nishadil Drive Nishadil Finance Nishadil Pay Nishadil Weather Nishdil Calendar Rewards
Signup Signin
Washington | 27°C (overcast clouds)
Topic Feed

VertexPharmaceuticals

Showing the latest stories and updates for this topic.
Vertex Pharmaceuticals Makes a Major Play, Acquiring Crinetics in a Near-$5 Billion Deal

Vertex Pharmaceuticals Makes a Major Play, Acquiring Crinetics in a Near-$5 Billion Deal
Biotech Power Play: Vertex's Bold Leap into Endocrine Therapies

Biotech Power Play: Vertex's Bold Leap into Endocrine Therapies
A $10 Billion Shake-Up: Vertex Pharmaceuticals to Acquire Crinetics in Major Cash Deal

A $10 Billion Shake-Up: Vertex Pharmaceuticals to Acquire Crinetics in Major Cash Deal
Vertex's Bold $10 Billion Bet: Reshaping the Biotech Landscape

Vertex's Bold $10 Billion Bet: Reshaping the Biotech Landscape
Vertex Pharmaceuticals Shines Bright: A Major Leap in Kidney Disease Treatment

Vertex Pharmaceuticals Shines Bright: A Major Leap in Kidney Disease Treatment
A Glimmer of Hope for Kidney Disease: Vertex's Breakthrough in IgA Nephropathy

A Glimmer of Hope for Kidney Disease: Vertex's Breakthrough in IgA Nephropathy
Vertex's Kidney Drug Breakthrough: A New Dawn for Autoimmune Disease and Soaring Stocks

Vertex's Kidney Drug Breakthrough: A New Dawn for Autoimmune Disease and Soaring Stocks
A New Dawn in Pain Relief: Vertex Pharmaceuticals' Breakthrough Soars Stock

A New Dawn in Pain Relief: Vertex Pharmaceuticals' Breakthrough Soars Stock
Vertex's Pivotal Moment: Beyond CF, What to Expect from Q4 Earnings

Vertex's Pivotal Moment: Beyond CF, What to Expect from Q4 Earnings
CRISPR Therapeutics: Beyond the Hype, A Foundational Investment in Gene Editing's Future

CRISPR Therapeutics: Beyond the Hype, A Foundational Investment in Gene Editing's Future
Wall Street Weighs In: Top Analyst Calls Spark Market Chatter This Tuesday

Wall Street Weighs In: Top Analyst Calls Spark Market Chatter This Tuesday
The Great Weight Shift: Biotech's Quest for What's Next in Obesity Care

The Great Weight Shift: Biotech's Quest for What's Next in Obesity Care
Soaring Horizons: Cystic Fibrosis Therapeutics Market Set to Skyrocket to $39.15 Billion by 2034

Soaring Horizons: Cystic Fibrosis Therapeutics Market Set to Skyrocket to $39.15 Billion by 2034
Vertex Pharmaceuticals: A Biopharma Behemoth Fortified by CF Dominance and a Groundbreaking Pain Pipeline

Vertex Pharmaceuticals: A Biopharma Behemoth Fortified by CF Dominance and a Groundbreaking Pain Pipeline
Unpacking Today's Top Stock Insights: AbbVie, Vertex, Veeva, and Vistra Under the Microscope

Unpacking Today's Top Stock Insights: AbbVie, Vertex, Veeva, and Vistra Under the Microscope
A New Dawn for Type 1 Diabetes: Stem Cell Therapy Restores Natural Insulin Production

A New Dawn for Type 1 Diabetes: Stem Cell Therapy Restores Natural Insulin Production
Load more..